Humacyte

HUMA stock is not Shariah-compliant

Powered by the Zoya API

About Humacyte (HUMA)

Humacyte engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across multiple therapeutic areas. The company uses its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) designed to be easily implanted into any patient without inducing a foreign body response or immune rejection. It is developing a portfolio of HAVs targeting the vascular repair, reconstruction, and replacement market, including vascular trauma, arteriovenous access for hemodialysis, peripheral arterial disease, coronary artery bypass grafting, pediatric heart surgery, and cellular therapy delivery like pancreatic islet cell transplantation for Type 1 diabetes.

Frequently asked questions

Is Humacyte (HUMA) stock halal to invest in?
As of , HUMA is not Shariah-compliant and therefore considered halal to invest in. This assessment is based on the data available in Humacyte's most recent financial reports.
As of , HUMA is not Shariah-compliant and therefore not considered halal to invest in. This assessment is based on the data available in Humacyte's most recent financial reports.
As of , HUMA is flagged as not Shariah-compliant in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Humacyte's business that require careful consideration.
Does Humacyte have any interest income?
Yes, Humacyte does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Humacyte reported revenue of 0 and interest income of 0. The interest income represents 0% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Humacyte has not reported any interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Humacyte reported total revenue of 0, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Humacyte stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions (AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes standards for Islamic finance. Their guidelines help determine if a company's business activities and financial structure align with Islamic principles. These standards are widely respected in the Islamic finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Humacyte stock reviewed for Shariah compliance?
The Shariah compliance status of Humacyte stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Humacyte's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of HUMA, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Humacyte stock considered halal?
Yes, dividends from HUMA are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Humacyte (HUMA), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from HUMA are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Humacyte shares?
If you hold Humacyte stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculator for stocks. For a more seamless experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Humacyte (HUMA) stock on Zoya

  1. Sign up for a free Zoya account
    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Zoya app for iOS or Android.
  2. Link a brokerage account
    Zoya partners with leading brokerages like Alpaca and others for a seamless way to buy and manage stocks through Zoya.
  3. Decide how much to invest
    Navigate to the search screen and type the name of the stock into the search bar. Then, click the buy button and input the amount you'd like to invest, either in terms of dollars or number of shares. Review the real-time stock price and estimated quantity of shares before confirming your investment.
  4. Manage your portfolio in one place
    You can find your newly purchased stock in your Zoya portfolio alongside the rest of your holdings. Enable alerts to get notified of any changes in your portfolio's Shariah compliance.

Community posts

Related stocks

See how Humacyte compares with its peers: